Figure 2From: What have we learned from cancer immunotherapy in the last 3 years? Kaplan-Meier curves of OS in patients treated with ipilimumab. OS curves from two randomised phase 3 trials of ipilimumab in patients with metastatic melanoma: A) MDX010-20 trial, and B) CA184-024 trial.Back to article page